Treatment of adults (≥18 years) with the following bacterial infections caused by susceptible strains:
Respiratory tract infections eg, acute exacerbations of chronic bronchitis; acute sinusitis; community-acquired pneumonia (CAP) including CAP caused by multidrug-resistant strains. Multidrug-resistant Streptococcus pneumoniae (MDRSP) includes isolates known as penicillin-resistant S. pneumoniae (PRSP) and strains resistant to ≥2 of the following antibiotics: Penicillin (MIC ≥2 mcg/mL), 2nd generation cephalosporins (eg, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole.
Uncomplicated skin and skin structure infections. Complicated skin and skin structure infections (including diabetic foot infections).
Uncomplicated pelvic inflammatory disease (ie, infections of female upper genital tract, including salpingitis and endometritis).
Complicated intra-abdominal infections including polymicrobial infections eg, abscesses.